A Comprehensive Examination of Severely Ill ME/CFS Patients.
Chang, Chia-Jung, Hung, Li-Yuan, Kogelnik, Andreas M et al. · Healthcare (Basel, Switzerland) · 2021 · DOI
Quick Summary
This study examined severely ill ME/CFS patients who are mostly housebound or bedbound—a group that hasn't received much research attention. Researchers found that fatigue, pain, and thinking difficulties were the most common complaints, and patients showed distinct sleep problems and hormone imbalances. The study suggests that ME/CFS and long COVID may share similar mechanisms, meaning treatments discovered for one condition could potentially help the other.
Why It Matters
This study addresses a critical research gap by focusing on the most severely affected ME/CFS patients, whose experiences are often underrepresented in clinical research. The identification of consistent biological abnormalities (cortisol dysfunction, sleep architecture changes) and the proposed mechanistic similarities with long COVID could accelerate development of diagnostic tests and treatments. Understanding severe ME/CFS may also inform prevention and management strategies for long COVID.
Observed Findings
Fatigue affected 85% of severely ill patients, with pain (65%), cognitive impairment (50%), and orthostatic intolerance (45%) also highly prevalent
Patients demonstrated distinctive abnormalities in sleep profiles and cognitive testing compared to healthy controls
Lower morning cortisol levels and disrupted diurnal cortisol rhythm were observed in ME/CFS patients
No evidence of acute infections by common viral or bacterial pathogens was detected via antibody and antigen measurements
Quality of life was negatively correlated with clinical depression in the patient cohort
Inferred Conclusions
ME/CFS in its severe form represents a distinct clinical and biological entity warranting focused research and development of molecular diagnostic tests
Hormonal dysregulation (cortisol abnormalities) and sleep architecture disturbances are consistent features of severe ME/CFS
The mechanistic overlap between ME/CFS and long COVID suggests bidirectional benefits from studying both conditions
Severe ME/CFS patients are understudied despite representing one in four affected individuals and warrant inclusion in future research protocols
Remaining Questions
Are the observed cortisol abnormalities and sleep disturbances primary disease mechanisms or secondary consequences of severe illness?
What This Study Does Not Prove
This study cannot establish causation—for example, cortisol abnormalities may result from severe illness rather than cause the disease. The cross-sectional design cannot determine whether observed symptoms and laboratory findings are primary disease mechanisms or secondary consequences of prolonged immobility and illness. The absence of acute infection markers does not rule out persistent viral reservoirs or post-infectious immune dysregulation.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
What specific molecular or biomarkers could reliably distinguish ME/CFS from other conditions and predict disease severity?
How do the biological findings in severe ME/CFS compare to milder forms of the disease, and what determines disease severity?
What are the shared and distinct pathogenic mechanisms between ME/CFS and long COVID, and can treatments developed for one condition effectively treat the other?